23andMe rises 17% on FDA clearance to report more genetic variants
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.